Literature DB >> 21178004

IFN regulatory factor 8 restricts the size of the marginal zone and follicular B cell pools.

Jianxun Feng1, Hongsheng Wang, Dong-Mi Shin, Marek Masiuk, Chen-Feng Qi, Herbert C Morse.   

Abstract

Transcriptional control of marginal zone (MZ) and follicular (FO) B cell development remains incompletely understood. The transcription factor, IFN regulatory factor (IRF)8, is known to play important roles in the differentiation of early B cells. In this article, we demonstrate that IRF8 is also required for normal development of MZ and FO B cells. Mice with a conventional knockout of Irf8 (IRF8(-/-)) or a point mutation in the IRF association domain of IRF8 had increased numbers of MZ B cells. To determine the B cell-intrinsic effects of IRF8 deficiency, we generated mice with a conditional allele of Irf8 crossed with CD19-Cre mice (designated IRF8-conditional knockout [CKO]). These mice had enlarged MZ and increased numbers of MZ and FO B cells compared with controls. The FO B cells of CKO mice exhibited reduced expression of CD23 and moderately increased expression of CD21. Gene-expression profiling showed that increased B cell production in IRF8-CKO mice was associated with changes in expression of genes involved in regulation of transcription, signaling, and inflammation. Functional studies showed that IRF8-CKO mice generated normal Ab responses to T-independent and T-dependent Ags. Thus, IRF8 controls the expansion and maturation of MZ and FO B cells but has little effect on B cell function.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21178004      PMCID: PMC3406599          DOI: 10.4049/jimmunol.1001950

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  48 in total

1.  IFN regulatory factor 4 and 8 promote Ig light chain kappa locus activation in pre-B cell development.

Authors:  Shibin Ma; Anna Turetsky; Long Trinh; Runqing Lu
Journal:  J Immunol       Date:  2006-12-01       Impact factor: 5.422

2.  Analysis of the individual contributions of Igalpha (CD79a)- and Igbeta (CD79b)-mediated tonic signaling for bone marrow B cell development and peripheral B cell maturation.

Authors:  Ezequiel M Fuentes-Pananá; Gregory Bannish; Fredrick G Karnell; John F Treml; John G Monroe
Journal:  J Immunol       Date:  2006-12-01       Impact factor: 5.422

Review 3.  The IRF family transcription factors in immunity and oncogenesis.

Authors:  Tomohiko Tamura; Hideyuki Yanai; David Savitsky; Tadatsugu Taniguchi
Journal:  Annu Rev Immunol       Date:  2008       Impact factor: 28.527

4.  The feedback phase of type I interferon induction in dendritic cells requires interferon regulatory factor 8.

Authors:  Prafullakumar Tailor; Tomohiko Tamura; Hee Jeong Kong; Toru Kubota; Mayumi Kubota; Paola Borghi; Lucia Gabriele; Keiko Ozato
Journal:  Immunity       Date:  2007-08-16       Impact factor: 31.745

5.  Early growth response genes regulate B cell development, proliferation, and immune response.

Authors:  Murali Gururajan; Alan Simmons; Trivikram Dasu; Brett T Spear; Christopher Calulot; Darrell A Robertson; David L Wiest; John G Monroe; Subbarao Bondada
Journal:  J Immunol       Date:  2008-10-01       Impact factor: 5.422

6.  Synergism between NF-kappa B1/p50 and Notch2 during the development of marginal zone B lymphocytes.

Authors:  Stewart T Moran; Annaiah Cariappa; Haoyuan Liu; Beth Muir; Dennis Sgroi; Cristian Boboila; Shiv Pillai
Journal:  J Immunol       Date:  2007-07-01       Impact factor: 5.422

7.  Interferon regulatory factors 4 and 8 induce the expression of Ikaros and Aiolos to down-regulate pre-B-cell receptor and promote cell-cycle withdrawal in pre-B-cell development.

Authors:  Shibin Ma; Simanta Pathak; Long Trinh; Runqing Lu
Journal:  Blood       Date:  2007-10-30       Impact factor: 22.113

8.  Constitutive alternative NF-kappaB signaling promotes marginal zone B-cell development but disrupts the marginal sinus and induces HEV-like structures in the spleen.

Authors:  Feng Guo; Debra Weih; Elke Meier; Falk Weih
Journal:  Blood       Date:  2007-07-09       Impact factor: 22.113

9.  The transcription factor Fli-1 modulates marginal zone and follicular B cell development in mice.

Authors:  Xian K Zhang; Omar Moussa; Amanda LaRue; Sarah Bradshaw; Ivan Molano; Demetri D Spyropoulos; Gary S Gilkeson; Dennis K Watson
Journal:  J Immunol       Date:  2008-08-01       Impact factor: 5.422

10.  The BXH2 mutation in IRF8 differentially impairs dendritic cell subset development in the mouse.

Authors:  Prafullakumar Tailor; Tomohiko Tamura; Herbert C Morse; Keiko Ozato
Journal:  Blood       Date:  2007-11-30       Impact factor: 22.113

View more
  48 in total

1.  Regulation of bifurcating B cell trajectories by mutual antagonism between transcription factors IRF4 and IRF8.

Authors:  Heping Xu; Virendra K Chaudhri; Zhiguo Wu; Konstantinos Biliouris; Krista Dienger-Stambaugh; Yrina Rochman; Harinder Singh
Journal:  Nat Immunol       Date:  2015-10-05       Impact factor: 25.606

2.  An osteopontin/CD44 immune checkpoint controls CD8+ T cell activation and tumor immune evasion.

Authors:  John D Klement; Amy V Paschall; Priscilla S Redd; Mohammed L Ibrahim; Chunwan Lu; Dafeng Yang; Esteban Celis; Scott I Abrams; Keiko Ozato; Kebin Liu
Journal:  J Clin Invest       Date:  2018-11-05       Impact factor: 14.808

3.  IFN regulatory factor 8 represses GM-CSF expression in T cells to affect myeloid cell lineage differentiation.

Authors:  Amy V Paschall; Ruihua Zhang; Chen-Feng Qi; Kankana Bardhan; Liang Peng; Geming Lu; Jianjun Yang; Miriam Merad; Tracy McGaha; Gang Zhou; Andrew Mellor; Scott I Abrams; Herbert C Morse; Keiko Ozato; Huabao Xiong; Kebin Liu
Journal:  J Immunol       Date:  2015-02-02       Impact factor: 5.422

Review 4.  The generation of antibody-secreting plasma cells.

Authors:  Stephen L Nutt; Philip D Hodgkin; David M Tarlinton; Lynn M Corcoran
Journal:  Nat Rev Immunol       Date:  2015-02-20       Impact factor: 53.106

5.  Cutting edge: IRF8 regulates Bax transcription in vivo in primary myeloid cells.

Authors:  Jine Yang; Xiaolin Hu; Mary Zimmerman; Christina M Torres; Dafeng Yang; Sylvia B Smith; Kebin Liu
Journal:  J Immunol       Date:  2011-09-26       Impact factor: 5.422

Review 6.  Cellular and chromatin dynamics of antibody-secreting plasma cells.

Authors:  Alexandra Bortnick; Cornelis Murre
Journal:  Wiley Interdiscip Rev Dev Biol       Date:  2015-10-21       Impact factor: 5.814

7.  Essential requirement for IRF8 and SLC15A4 implicates plasmacytoid dendritic cells in the pathogenesis of lupus.

Authors:  Roberto Baccala; Rosana Gonzalez-Quintial; Amanda L Blasius; Ivo Rimann; Keiko Ozato; Dwight H Kono; Bruce Beutler; Argyrios N Theofilopoulos
Journal:  Proc Natl Acad Sci U S A       Date:  2013-02-04       Impact factor: 11.205

8.  A role for IRF8 in B cell anergy.

Authors:  Simanta Pathak; Shibin Ma; Vipul Shukla; Runqing Lu
Journal:  J Immunol       Date:  2013-11-11       Impact factor: 5.422

9.  Mutations in linker histone genes HIST1H1 B, C, D, and E; OCT2 (POU2F2); IRF8; and ARID1A underlying the pathogenesis of follicular lymphoma.

Authors:  Hongxiu Li; Mark S Kaminski; Yifeng Li; Mehmet Yildiz; Peter Ouillette; Siân Jones; Heather Fox; Kathryn Jacobi; Kamlai Saiya-Cork; Dale Bixby; Daniel Lebovic; Diane Roulston; Kerby Shedden; Michael Sabel; Lawrence Marentette; Vincent Cimmino; Alfred E Chang; Sami N Malek
Journal:  Blood       Date:  2014-01-16       Impact factor: 22.113

10.  IRF4 and IRF8 Act in CD11c+ Cells To Regulate Terminal Differentiation of Lung Tissue Dendritic Cells.

Authors:  Sandra Bajaña; Sean Turner; Jinny Paul; Erola Ainsua-Enrich; Susan Kovats
Journal:  J Immunol       Date:  2016-01-08       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.